Wednesday, October 3, 2012

Innovative Strategies for Individualized Health Care - November 1-4 Hyderabad


 
.
News & PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Innovative Strategies for Individualized Health Care
KEYNOTE SPEAKER

Paul Huckle
Senior Vice President
Global Regulatory Affairs
GlaxoSmithKline
DIA India’s 7th Annual Conference: "Discovery Through Commercialization - Innovative Strategies for Individualized Health Care" is your only chance this year to interact and network with the largest gathering of International and Indian Regulators and Pharma professionals in India.
This year at Hyderabad International Convention Centre (HICC), Hyderabad, this conference and exhibition will bring together over 400 of your key past, present and future patrons.
There are over 100 international and Indian industry leaders who will present and discuss pertinent and relevant issues in 25 key sessions on topics related to Drug Discovery, Development, Manufacturing, Commercialization, Regulatory, Ethical, Social, Legal, Technology & Standards, Lean Strategy, Outsourcing Strategy, Pharmacovigilance and Therapeutics.
For more information please click here to view the conference brochure or contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798.
Participant Profile of Last Year's Conference Attendees
- - - - - - - - - - - - - - - - -
Program Highlights
  • Discovery: Bioinformatics, Next Gen Sequencing, Lead optimization – the need for speed
  • Development: Barriers and drivers relevant to clinical development across clinical operations, data management, biostatistics, programming, and medical writing, highlighting systems biology paradigm (e.g. pharmacogenomics, metabolomics) and innovative developmental approaches (e.g. chronotherapeutics, microdosing)
  • Manufacturing: Flexible solutions to adapt to the evolving global regulatory scenario and quality standards
  • Commercialization: Health economics and outcomes research driving product and pricing strategy, patient access, payor challenges, Go-to-investors and financial/partnering strategies for product development
  • Regulatory, ethical, social and legal issues: Data privacy and consent issues in the evolving technologies related to personalized medicine
  • Technology and Standards: Technology – SOA, the Cloud and the future, Data and Semantic Interoperability Technology, GRC (Governance, Regulation and Compliance) all focused on Personalized Medicine. 
  • Lean strategy: The application of Lean in pharmacovigilance, medical writing, clinical operations and site performance. Driving the critical path.
The conference will address the strategy for drug discovery and clinical development pipeline and faster time to market in the era of blockbuster patient expiries and issues of integrating and streamlining data flows across the entire life cycle of the molecule, and the standardization and rigor that needs to be implemented.
It will also stress upon the ethical, legal, social and regulatory and financial and investments challenges impacting all of the above and how processes and technology will need to be upgraded to support the same.
To know more contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798.
Exhibit Details
With over 9500 square feet of area the exhibition this year hosted at Hyderabad International Convention Centre (HICC), will help you connect with over 400 patrons. As an exhibitor you will be entitled to:
  • Two complimentary conference passes
  • Two complimentary exhibit booth attendee passes
  • Pre-fitted shell scheme booth structure
  • Fascia board with 25 character company name
  • One electrical connection
  • Three spotlights
  • One table
  • Two chairs
  • One wastebasket
  • Carpet
Exhibit Fee: 3m x 2m booth space - INR 168,540/- (inclusive of taxes)
Please click here to view the Exhibit Layout and Booking Form. For more details contact Manoj.Trivedi@diaindia.org  or call +91.98.1977.7493.
Email Preferences    |    My DIA    |    Forward to a Friend    |    FacebookLinkedInTwitterYouTube
 

No comments:

Post a Comment